Although the role of the RAS has been extensively studied in COVID-19 patients, there are, unquestionably, information gaps concerning this topic, especially regarding the role of AT1-inverse agonists and their mechanism action in SARS-CoV-2 infection. This evidence concerns the gene AGTR1 and COVID-19.